| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | CAL-101 | GDSC1000 | pan-cancer | AAC | 0.17 | 1e-06 |
| mRNA | nelarabine | CTRPv2 | pan-cancer | AAC | 0.19 | 2e-06 |
| mRNA | PD-0332991 | GDSC1000 | pan-cancer | AAC | 0.19 | 3e-06 |
| mRNA | MI-2 | CTRPv2 | pan-cancer | AAC | 0.25 | 3e-06 |
| mRNA | KIN001-102 | GDSC1000 | pan-cancer | AAC | 0.16 | 3e-06 |
| mRNA | ABT-199 | CTRPv2 | pan-cancer | AAC | 0.2 | 5e-06 |
| mRNA | RO4929097 | CTRPv2 | pan-cancer | AAC | 0.25 | 5e-06 |
| mRNA | BRD-K42260513 | CTRPv2 | pan-cancer | AAC | 0.25 | 5e-06 |
| mRNA | carboplatin:etoposide (40:17 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.14 | 6e-06 |
| mRNA | JNJ-26854165 | CTRPv2 | pan-cancer | AAC | 0.15 | 7e-06 |